Lp-PLA2-IN-12 (compound 19), an Lp-PLA2 inhibitor, is utilized in researching neurodegenerative diseases including Alzheimers disease (AD), glaucoma, age-related macular degeneration (AMD), and cardiovascular conditions such as atherosclerosis [1].
Molecular Weight:
467.47
CAS Number:
[2637485-14-2]
Formula:
C24H23F2N5O3
Target:
Phospholipase
* VAT and and shipping costs not included. Errors and price changes excepted